Rituximab for Schizophrenia Spectrum Disorder (RITS-PS-2019)

Clinical trial NCT03983018 · COMPLETED

Trial details

NCT number: NCT03983018
Sponsor: Region Örebro County
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Schizophrenia Spectrum and Other Psychotic Disorders Treatment-resistant Schizophrenia

Start date: 2019-08-07
Primary completion: 2022-03-31
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.